Opinions
Bruce Murray
Chromos Molecular Systems Inc.
CHR-T Unlisted
BUY
Jul 13, 2016
$0.040
Stock price when the opinion was issued
biotechnology
pharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
You might be interested:
BUY
Likes the story. They’ve switched their contract and he feels the company came out very well in the negotiations. They moved from a spread over costs which Air Canada (AC-T) used to pay, to a fixed price contract, which is very good for this company. Over the duration of the 10 years that the contract was reset for, the dividend is sustainable.
biotechnology
pharmaceutical
(Market Call Minute) They love it. The company is not responsible for any of the variable costs.